Stay updated with breaking news from ஈயந் வாடெல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inside the secret world of Britain's nuclear submarine industry telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.
The debate about the debate that could swing the election politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
BARROW S shipyard workers are trying their damnedest to deliver the next generations of nuclear submarines amid criticism of delays. Union boss Ian Waddell, paid tribute to the thousands of workers building the Dreadnought and Astute programmes of nuclear submarines at Barrow s shipyard. He spoke at the at of parliament s Defence Committee after one MP criticised delays in delivery of Astute submarines. Conservative MP Mark Francois said: The Astute programme is not an encouraging precursor to the Dreadnought programme because if Dreadnought goes anything like Astute we ll lose continuity of the continuous at sea deterrent. That s why the committee is particularly concerned. ....
Conservatives look to use rarely-invoked tactic to rebuke head of Canada's public healthy agency cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Submitting. She was then instrumental in the company integration and broader CLS services strategy in her vice-president role. Clare Doris and Clare Wareing of Cumulus Oncology, which is based in Edinburgh. Picture: Stewart Attwood Clare Wareing, chief executive and co-founder of Cumulus Oncology, said: “In her role at Aquila, Clare was instrumental in transforming the company from a start-up to a successful specialist service provider, while leading collaborations supporting value creation and fundraising efforts for a range of biotech companies. “This kind of experience is a great fit for where we are at on the Cumulus journey, with our own plans to scale the business over the next few years.” ....